Page last updated: 2024-11-12

lactoferricin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

lactoferricin B: amino acid sequence given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16132444
MeSH IDM0219018

Synonyms (3)

Synonym
146897-68-9
l-phenylalanine, l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-
lactoferricin b

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"The effects of lactoferrin (LF), an antimicrobial protein secreted in body fluids, and its peptides in combination with azole antifungal agents were investigated by the micro-broth-dilution method in a study of Candida albicans."( Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents.
Abe, S; Kawase, K; Okutomi, T; Tansho, S; Wakabayashi, H; Yamaguchi, H, 1996
)
0.29
" Synergy was observed between both LF or Lfcin in combination with ACV against the HSV laboratory strains."( Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir.
Andersen, JH; Gutteberg, TJ; Jenssen, H, 2003
)
0.32

Bioavailability

ExcerptReferenceRelevance
" Higher amounts of Doxo (195 µg/g) were removed through kidney, while Apodoxonano and Lactodoxonano showed only a minimal amount of removal (<40 µg/g), suggesting the extended bioavailability of Doxo when delivered through nanoformulation."( Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats.
Ahmed, F; Cherukuvada, B; Golla, K; Kondapi, AK, 2012
)
0.38
"Drug delivery through nanoformulations not only minimizes the cardiotoxicity of doxorubicin but also enhances the efficacy and bioavailability of the drug in a target-specific manner."( Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats.
Ahmed, F; Cherukuvada, B; Golla, K; Kondapi, AK, 2012
)
0.38

Dosage Studied

ExcerptRelevanceReference
" When resistance against Vibrio parahaemolyticus in shrimp is considered, high dosage of Bovine lactoferricin showed a better effect than low dosage of Bovine lactoferricin."( Effect of bovine lactoferricin on the growth performance, digestive capacity, immune responses and disease resistance in Pacific white shrimp, Penaeus vannamei.
Huang, H; Liu, XL; Wang, NA; Zhong, GF; Zhuang, Y, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (244)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's27 (11.07)18.2507
2000's84 (34.43)29.6817
2010's107 (43.85)24.3611
2020's26 (10.66)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (0.81%)5.53%
Reviews15 (6.10%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other229 (93.09%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]